Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Arete Rehab Continues Rapid Growth Into Mid-Atlantic Region With Recent Acquisition


News Image

“I found an extraordinary partner. Arete’s philosophy and ideals are identical to SPTS’s. It’s all about the patients and their needs and everything else will take care of itself,” said Steve Sherer, Owner SPTS

Arete Rehabilitation, Inc. and PA based Senior Physical Therapy Services (SPTS) announced today that Arete has acquired SPTS, a post-acute provider of physical, occupational, speech therapy, and wellness services for the 65 and older generation. The acquisition of this exceptional team of therapists accelerates Arete’s plan to expand into the Mid-Atlantic region.

“Arete’s commitment to providing excellence in both Skilled Nursing Inpatient and Community Based Outpatient rehab services and high quality alternative employment opportunities for therapists, makes the SPTS acquisition a win-win for patients and therapists alike,” said Janet Mahoney, DPT, CEO of Arete Rehabilitation, Inc. “The first step in any acquisition is getting the right team together. SPTS brings dedicated, experienced therapists and employees and we are excited to welcome Steve and his team. Bringing on this fabulous group significantly advances our Mid-Atlantic expansion plan.”

“I found an extraordinary partner. Arete’s philosophy and ideals are identical to SPTS’s. It’s all about the patients and their needs and everything else will take care of itself,” said Steve Sherer, Owner SPTS.

The SPTS group will provide important contributions to the rehab and wellness service arena as Arete is now able to provide a full spectrum of services, from skilled nursing to home care to outpatient in outpatient clinics, in the community and in patient homes.

Visit the Arete Rehab website for more information.

Share article on social media or email:

EnSoftek’s DrCloudEHR™ is selected by Freedom Healthcare and Curry Community Health to support their mission


News Image

“DrCloudEHR checked all of the boxes for us with their well-organized platform that is fully integrated into all of the services we provide. The employees of DrCloudEHR… are connected to the buyer, understand their product capabilities, and know what applications will be a good fit.” Kenneth Dukek

As nonprofit charitable organizations, both Freedom Healthcare (FHC) and Curry Community Health (CCH), provide mental health and psychiatric services in Nevada and Oregon, respectfully. Committed to delivering best practices with flexibility and compliance while leveraging the latest technologies and always on, always available architecture, EnSoftek’s DrCloudEHR is their Electronic Health Record (EHR) of choice.

“Beginning in late 2013, we saw the need for telehealth services to improve client multipoint access to mental health services. As COVID-19 became a major threat to our way of life, we quickly modified our services in order to provide about 90% of our services remotely. Telehealth requires an intuitive and comprehensive Electronic Health Record (EHR) to support robust services. Our organizations were specifically looking for one EHR to support e-prescribing, appointment scheduling, text reminders, patient portal, payment processing, reporting, and connectivity to Zoom. After extensive market research that included presentations by the top three providers, we chose DrCloudEHR. Freedom Healthcare expects to be operational by January, 2021 and Curry Community Health will begin using DrCloudEHR in July, 2021.” said Kenneth W. Dukek, Freedom Healthcare, Inc. President & CEO, Curry Community Health, Inc. CEO.

“DrCloudEHR checked all of the boxes for us with their well-organized platform that is fully integrated into all of the services we provide. The employees of DrCloudEHR that provided the presentation and led us through the contract phase are connected to the buyer, understand their product capabilities, and know what applications will be a good fit. We are excited about using an EHR that is fully integrated because we are currently using two EHR’s, Excel, and other software to manage the billing, prescribing, and charting. We are looking forward to a successful DrCloudEHR transition!” added Kenneth Dukek.

“EnSoftek mission is to provide solutions that are the right “Fit” and that are most “Helpful”. Our philosophy extends throughout our entire company to foster a true understanding of the needs of our Customers. We welcome Freedom and Curry to our growing family of provider agency Customers/Partners.” said Adam Feldman, Senior Vice President Business Development.

About DrCloudEHR™ and EnSoftek, Inc.

Currently in use in 26 states throughout the country, DrCloudEHR from EnSoftek is a meaningful use stage 3 certified (supporting Interoperability), native cloud electronic health records (EHR) system designed for behavioral health and human services organizations. DrCloudEHR, available with anytime, anywhere access, helps our customers deliver better services, improve patient care, engagement, health outcomes; and provide better overall patient satisfaction – making it the preferred solution for current and future behavioral health, health and human services, and integrated care providers. EnSoftek provides diversified enterprise IT solutions to both public and private sector enterprises.

About Freedom Healthcare, Inc.

Freedom Healthcare (FHC) is a nonprofit charitable 501(c)(3) corporation, staffed by professionals in a variety of specialized fields that provide mental health and psychiatric services to the general public. FHC’s mission statement is, “Supporting and promoting the health and well-being of our community.” Philosophically, our goal is to keep people in the community, rather than hospitalize or place in long-term care. FHC focuses on support systems, multipoint service access, promotes strong and healthy family development, and self-help, or wellness promotion.

About Curry Community Health, Inc.

Founded in 2013, Curry Community Health is a 501(c)(3) non-profit organization which provides behavioral health services and programs in Curry County, OR. CCH operates community service clinics in Gold Beach and Brookings. Curry Community Health supports and promotes the health and well-being of the community.

Follow us on Twitter, LinkedIn, and Facebook.

http://www.drcloudehr.com; http://www.ensoftek.com

Share article on social media or email:

This New CBD Brand is Changing The Way CBD is Delivered


The New CBD Brand Changing The Way CBD is Delivered.

Whether a consumer’s daily dose of CBD is delivered via a tincture, a topical or a gummy, Cannabinoid Balance by CBD Products Inc. has a product to suit. Introducing the NEW Cannabinoid Products line up for consumers who want high dosage CBD with exceptional efficiency.

The Cannabinoid Balance product family:

Cannabinoid Balance Original + 1000mg & 3000mg

Broad Spectrum CBD Tincture with high absorption NanoZorb™ Technology. Supporting the symptoms of MS, Parkinsons, Opioid Addiction, Epilepsy, High Blood Pressure, Stress, Anxiety, Low Energy, Arthritis, Tendonitis and more…*

Cannabinoid Balance Sleep + 1000mg

Water Soluble CBD + Melatonin with high absorption NanoZorb™ Technology. Supporting the body’s natural sleep cycle.*

Cannabinoid Balance CBD Gummies+ 750mg

Broad Spectrum CBD Vegan Gummies with high absorption NanoZorb™ Technology. Great tasting daily CBD dosing.*

Cannabinoid Balance Pain Relief Cream+ 1000mg

Broad Spectrum CBD Topical with high absorption NanoZorb™ Technology. Fast-acting relief for skin complaints, general soreness of joints and inflammation.*

Cannabinoid Balance products are all-natural and free of synthetics, sugar, binders, fillers, wax, shellac, talcum, and animal gelatin. It contains no yeast, wheat, corn, soy, gluten, salt, dairy, artificial flavors, sweeteners, colors, or preservatives. Honest Cannabinoids. Simply Balanced.

*The statements and products referred to by Cannabinoid Balance have not been evaluated by the FDA.

—

NOTES TO THE EDITOR

—

CBD Products Inc. is a multi-channel, CBD publishing and retail company established in 2018 that owns and operates cbdproducts.com, cbdworldnews.com and cbdpet.com. In the last year CBD Products Inc. has welcomed more than 25,000 people to their sites and offered information and resources across more than 100,000 page views.

CBD Products Inc. is also the owner of Cannabinoid Balance. A line of consumer products that includes Cannabinoid Balance Original+, Cannabinoid Balance Sleep+, Cannabinoid Balance CBD Gummies+, Cannabinoid Balance Pain Relief Cream and Cannabinoid Balance Pet+. These products are sold via http://www.cbdproducts.com and include proprietary NanoZorb™ Technology designed to make Cannabinoid Balance products more effective and efficient.

It was founded by Anthony Tribunella in 2018. Anthony has worked in all aspects of the industry from growing to production, to publishing and retailing. With more than a decade of experience in CBD and a passion to see the industry become organized and honest, Anthony is rapidly becoming a shining light, thought leader and conscience for the industry he cares so deeply about.

For more information on CBD Products Inc. please visit http://www.cbdproducts.com or email contact@cbdproducts.com.

Share article on social media or email:

Makers Nutrition Wins A Record Number of Pillar World Awards®, Globee® Awards, and Customer Sales and Service World® Awards in 2020 SVUS Lineup


2020 Pillar, Globee, and Customer Sales and Service Awards

This further validates our position as a company poised to successfully overcome any issue the supplement industry faces, and our team’s exemplary collaboration during COVID-19 makes me even prouder to be leading such an extraordinary organization.

Makers Nutrition announced today that it has been recognized in the 5th Annual 2020 Pillar World Awards®, 7th Annual Globee Awards, and 7th Annual Customer Sales & Service World Awards®.

Most noteworthy this year are Makers Nutrition’s wins in the Pillar World Awards®, as the company has been honored with an astounding 14 titles, including several related to its COVID-19 response.

The coveted annual Pillar World Awards® is the world’s premier awards program honoring the best employers, employees, and HR achievements. Recognition is especially meaningful during the current business environment and times. The Pillar World Awards have issued the final call for 2020 entries that will recognize achievements of Best Employers, Diversity, Individuals and Teams, New HR Product, Service or Innovation, HR Solution and Training Programs, Corporate Milestones, Outstanding Employee, Customer, or Contractor, and COVID-19 Business Response.

Judges from a broad spectrum of industry voices from around the globe participated and their average scores determined the 2020 award winners in the Pillar World Awards®, as well as the Globee® and Customer Sales and Service Awards® programs. Winners will be celebrated and presented their awards during a virtual awards ceremony in December.

Makers Nutrition garnered the following titles in the 2020 Pillar World®, Customer Sales and Service®, and Globee® Awards:

2020 Pillar World Awards®

1. GOLD – Jason Provenzano – Great Workplace for Leadership Commitment

2. GOLD – Jason Provenzano – Great Workplace of the Year – Business Products

3. GOLD – Jason Provenzano- Great Workplace of the Year – Business Services

4. GOLD – Jason Provenzano – Great Workplace of the Year – Consumer Products – Non-Durables

5. GOLD – Jason Provenzano – Great Workplace of the Year – Healthcare Products & Services

6. GOLD – Jason Provenzano – Great Workplace of the Year – Manufacturing

7. GOLD – Jason Provenzano – Great Workplace of the Year – USA

8. GOLD – Jason Provenzano – CEO of the Year (People-Focused)

9. GOLD – Achievement in Respectful Culture

10. GOLD – Company Rethinking of the Year

11. GOLD – Stephen Finnegan – Outstanding Employee of the Year

12. SILVER – Jason Provenzano – Executive Hero of the Year – Effective Leadership During COVID-19

13. BRONZE – Jason Provenzano – Employer of the Year – Stepping Up to Help Employees During COVID-19

14. BRONZE – Company Response of the Year

2020 Customer Sales and Service Awards®

1. GOLD – Best Sales Growth Achievement of the Year

2. GOLD – Sales Outstanding Performance of the Year – Healthcare, Pharmaceuticals, and Related Industries

3. GOLD – Sales Outstanding Performance of the Year – Industrial & Manufacturing

4. GOLD – Customer Success

5. SILVER – Milestone of the Year – Sales

6. SILVER – Milestone of the Year – Customer Service & Support

7. SILVER – Milestone of the Year – Professional Services

2020 Globee® Awards

1. GOLD – Customer Satisfaction

2. GOLD – Company of the Year – Manufacturing

3. GOLD – Customer Service and Support Team-Department of the Year

4. GOLD – Jason Provenzano – Entrepreneur of the Year – Manufacturing

5. SILVER – Business-to-Business Services

6. SILVER – Stephen Finnegan – Executive Achievement of the Year – Manufacturing

“It’s an honor to be named a winner by each of these award programs,” said CEO and President of Makers Nutrition Jason Provenzano. “This further validates our position as a company poised to successfully overcome any issue the supplement industry faces, and our team’s exemplary collaboration during COVID-19 makes me even prouder to be leading such an extraordinary organization.”

For a complete list of the 2020 Pillar World Award, 2020 Customer Sales AND Service, and 2020 Globee Award winners, please visit https://pillarworldawards.com/winners/2020-pillar-awards-winners/, https://cssworldawards.com/winners/2020-sales-and-customer-service-awards/, and https://globeeawards.com/winners/2020-business-awards-winners/.

About the SVUS Awards

SVUS Awards are conferred in eleven programs: the CEO World Awards®, the Consumer World Awards®, The Customer Sales & Service World Awards®, The Globee® Awards, the Golden Bridge Awards®, the Info Security Products Guide’s Global Excellence Awards® and Security World Awards, the Network Products Guide’s IT World Awards®, One Planet® American + World Business Awards, the Pillar World Awards®, the PR World Awards® for Public Relations and Communications, and the Women World Awards®. Honoring organizations of all types and sizes and the people behind them, the SVUS Awards recognize outstanding achievements and performances in businesses worldwide. Learn more about the SVUS Awards at https://svusawards.com.

About Makers Nutrition

Makers Nutrition, an Inc. 5000 Fastest-Growing Company in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs. Click here to learn more.

Share article on social media or email:

Home Health and Hospice M&A Activity Jumped in Q3:2020, According to HealthcareMandA.com


News Image

Unlike most healthcare services sectors dealing with the COVID-19 pandemic, home health and hospice agencies are bouncing back to nearly pre-Covid-19 activity levels.

Deal volume in the home health and hospice sector accelerated in the third quarter of 2020, up 120% with 22 publicly announced transactions, compared with 10 acquisitions in the second quarter of 2020, according to data from HealthCareMandA.com and Deal Search Online. Compared with the same quarter in 2019, M&A activity increased by 10%.

The largest transaction in the third quarter was The Providence Service Corporation’s purchase of Simplura Health Group from One Equity Partners, for $575 million. Simplura operates a large network of home health and personal care agencies across Connecticut, Florida, Massachusetts, New Jersey, New York, Pennsylvania and West Virginia. It employs approximately 14,000 caregivers that provide over 20 million hours of non-medical personal care annually to primarily Medicaid patient populations, including seniors and disabled adults.

Addus HomeCare Corporation also announced a new transaction, acquiring A Plus Health Care, Inc. for $122 million. The acquisition will strengthen Addus’ presence in the Montana home health market.

“Unlike most healthcare services sectors dealing with the coronavirus pandemic, home health care and hospice agencies are bouncing back to nearly pre-Covid-19 levels of activity,” said Lisa E. Phillips, editor of The Health Care M&A Report, which publishes the data. “Analysts we’ve talked to expected to see a resurgence of deals in the sector beginning in the third quarter, and they were right. There’s good momentum going into the fourth quarter, too.”

In the third quarter, private equity firms and their sponsored companies remained active buyers, accounting for 43% of all deal activity. Caring People, a portfolio company of Silver Oak Services Partners, added providers in Connecticut, New York and Texas. Bristol Hospice, a portfolio company of Webster Equity Partners, announced two transactions, acquiring California-based Remita Health and VNA California, a nonprofit hospice and home health provider located in Southern California. Bristol Hospice partnered with HealthSure Management Services in that transaction.

All quarterly results are published in The Health Care M&A Report, which is part of the HealthCareMandA.com investment research source. For sector-specific research and analysis, please see The Home Health and Hospice Acquisition Report 2019. For information, or to order the reports, call 800-248-1668. Irving Levin Associates is celebrating more than 70 years of delivering exclusive M&A intelligence to its sophisticated audience of seniors housing and healthcare investors. The company was established in 1948 and has headquarters in New Canaan, Connecticut. The company publishes research reports and newsletters and maintains databases on the healthcare and senior housing M&A markets.

Share article on social media or email:

USOSM and Alamo Maxillofacial Surgical Associates Congratulate Dr. B.D. Tiner on His Inauguration as President of American Association of Oral and Maxillofacial Surgeons


Dr. B.D. Tiner is a surgeon with Alamo Maxillofacial Surgical Associates, headquartered in San Antonio.

I am excited and thankful to be working alongside so many skilled professionals as we work together to advance our great specialty.

The American Association of Oral and Maxillofacial Surgeons (AAOMS) has named Dr. B.D. Tiner, DDS, MD, FACS, as its new president. He officially began his one-year term on Oct. 11. Dr. Tiner served as president-elect for AAOMS last year, serving as vice president the year prior to that. He has been an active member of the organization for 37 years.

Dr. Tiner is a surgeon with Alamo Maxillofacial Surgical Associates, a partner practice of U.S. Oral Surgery Management (USOSM). Dr. Tiner’s private practice encompasses all areas of oral and maxillofacial surgery (OMS), including the management of obstructive sleep apnea, orthognathic surgery, dental implants and maxillofacial pathology.

He is a diplomate and past president of the American Board of Oral and Maxillofacial Surgery and a fellow of both AAOMS and the American College of Surgeons. Additionally, Dr. Tiner is an active member and past president of the Southwest Society of Oral and Maxillofacial Surgeons and the Texas Society of Oral and Maxillofacial Surgeons and serves as an ambassador for the Oral and Maxillofacial Surgery Foundation.

“Dr. B.D. Tiner is a dedicated and effective leader, and he’s one of the finest oral surgeons the industry has ever seen,” said Richard Hall, USOSM president and CEO. “It is a tremendous honor and responsibility to be named president of AAOMS, which is the industry’s largest professional organization dedicated to surgeon education and patient safety. Dr. Tiner will lead this organization and its people well, and we are excited to acknowledge his achievement and congratulate him by sharing this news.”

A former U.S. Navy Captain, and currently an adjunct clinical professor in the Department of Oral and Maxillofacial Surgery at the University of Texas Health Science Center at San Antonio, Dr. Tiner has served as a mentor and teacher to countless OMS students and professionals. In addition, he has authored or co-authored numerous scientific publications and book chapters.

Dr. Tiner holds a bachelor’s degree in zoology from Arkansas State University, a DDS from the University of Tennessee College of Dentistry and his MD from the University of Texas Medical School at San Antonio. Dr. Tiner’s post-graduate training included an internship in anesthesia and a residency in OMS at the University of Texas Health Science Center at San Antonio.

AAOMS is a nonprofit organization representing more than 9,000 oral and maxillofacial surgeons across the U.S. AAOMS strives to assure excellence in patient care by advancing, promoting and preserving the OMS specialty and the skill and professionalism of its members.

“I am honored and deeply humbled to serve as the 103rd President of the American Association of Oral and Maxillofacial Surgeons,” said Dr. Tiner. “I am excited and thankful to be working alongside so many skilled professionals as we work together to advance our great specialty.”

Headquartered in Irving, Texas, USOSM has partner practices spanning six states: Texas, Colorado, Georgia, Tennessee, Minnesota and Alabama. USOSM collaborates with premier oral and maxillofacial surgeons to offer a partnership solution for continued and accelerated practice success. USOSM provides operational, marketing and administrative support services, reinvests resources, and applies best practices to improve clinical and financial performance and produce steadier, more profitable growth for all.

Share article on social media or email:

Medically Home Group, Mass General Cancer Center Begin Trial of Home-Based Oncology Care


Medically Home Group today announced that it and its partner Massachusetts General Hospital Cancer Center (MGHCC) have begun enrolling patients in their randomized clinical trial of supportive oncology care in the home. Patients in the trial assigned to the intervention receive Medically Home’s supportive oncology care services that they would otherwise not receive. The patient-centered care is focused on managing patients’ symptoms, including side effects of their cancer treatments, and on reducing the likelihood that patients will need to return to a hospital for emergency or inpatient care.

The supportive oncology care service is built on the same high-acuity platform as Medically Home’s Acute Hospital Substitution Program, used by some of the country’s top health systems to offer acute-level inpatient hospitalization in the patient’s home. The Medically Home platform includes a 24/7 clinician-led Medical Command Center; a network of rapid-response clinical and non-clinical services, medications, equipment, and supplies brought to patients’ homes; and technology in the home and the Command Center for monitoring and communicating with patients with a high-acuity illness.

Clinical studies have shown that home hospitalization delivers improved patient outcomes, higher patient and clinician satisfaction, cost savings, lower mortality, and lower risk for readmissions. Patients are treated in the safe and familiar environment of the home, without the disruption, stress and disorientation that can be experienced by hospital inpatients.

“Once diagnosed with cancer, most patients have no choice but to engage with a complicated and fragmented health care system, designed to prioritize the needs of the health system itself and not the needs of patients or their families,” said Medically Home Oncology President Patricia “Patty” Brown. “Medically Home is dedicated to transforming the health care experience of individuals with illnesses such as cancer whose needs range from supportive help with symptom management to high-acuity hospital-level care that may be provided in the patient’s home. Once you commit to patient-centered care, you can flip the care delivery model on its head, leveraging the home as the preferred site of care.”

Under the clinical trial, Medically Home provides and coordinates services including daily monitoring of patient reported outcomes and vital signs, scheduled intravenous fluids, and home visits as needed to administer additional care such as IV anti-emetics. The Medically Home oncology team maintains daily communication with the primary oncologists caring for these patients at MGHCC.

“We are excited for the opportunity to offer this randomized trial to our patients, as we seek to improve the quality of life and care for patients with cancer and their families,” said Dr. Ryan Nipp, an oncologist at MGHCC. “This novel paradigm of care represents a promising solution to enhance care delivery and outcomes for patients with cancer, a population at risk for experiencing high symptom burden and frequent hospitalizations.”

For the study, 300 patients with pancreatic, gastroesophageal, rectal and head & neck cancers will be randomly selected to receive supportive oncology care at home by Medically Home over the course of their definitive (curative) chemotherapy or chemoradiation. The study is named Randomized Trial of a Supportive Oncology Care at Home Intervention for Patients with Cancer Receiving Definitive Treatment.

At a time when many clinical trials of oncology treatments have been halted by the COVID-19 pandemic, Medically Home’s platform allows trials to continue safely while reducing the need to bring patients into hospitals with restricted access.

“We believe that being able to participate in clinical trials from home will allow for greater enrollment, increased access, decreased patient and caregiver burden, increased health equity and decreased drop-out rates,” Brown said.

Brown came to Medically Home earlier this year after 25 years with Johns Hopkins Health System. In her most recent position, she served simultaneously as President of Johns Hopkins HealthCare, Senior Vice President of Managed Care and Population Health for Johns Hopkins Medicine, and Senior Counsel for the Johns Hopkins Health System.

About Medically Home

Medically Home is a technology-enabled services company that provides the clinical intellectual property, technology platform and acute rapid response clinical services that allow medical providers to safely shift advanced medical care from hospitals to patients’ homes. Through the company’s commitment to creating superior experiences and outcomes for patients, their families, and healthcare stakeholders, Medically Home with its customers and partners is leading the charge in the innovation of healthcare delivery. For more information on Medically Home, please visit http://www.medicallyhome.com/.

Share article on social media or email:

Thomas J. Fuchs, DSc, Named Dean of Artificial Intelligence and Human Health and Co-Director of the Hasso Plattner Institute for Digita Health at Mount Sinai


Thomas J. Fuchs, DSc, a prominent scientist in the groundbreaking field of computational pathology—the use of artificial intelligence to analyze images of tissue samples to identify disease and predict outcome—has been appointed Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai, Dean of Artificial Intelligence (AI) and Human Health, and Professor of Computational Pathology and Computer Science in the Department of Pathology at the Icahn School of Medicine at Mount Sinai. In his new role, he will lead the next generation of scientists and clinicians to use machine learning and other forms of artificial intelligence to develop novel diagnostics and treatments for acute and chronic disease.

“Dr. Fuchs has advanced the field of precision medicine through his contributions to artificial intelligence in pathology, helping the health care industry better understand and fight cancer. His expertise will enhance Mount Sinai’s continued efforts to use digital health to train future medical leaders and improve care for our patients,” said Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System. “By building on existing AI and health initiatives, like the Mount Sinai Digital and Artificial Intelligence-Enabled Pathology Center of Excellence, Dr. Fuchs’s guidance, along with shared knowledge and academic excellence from our team of researchers and clinicians, will help revolutionize health care and science, nationally and globally.”

Dr. Fuchs’s trailblazing work includes developing novel methods for analysis of digital microscopy slides to better understand genetic mutations and their influence on changes in tissues. He has been recognized for developing large-scale systems for mapping the pathology, origins, and progress of cancer. This breakthrough was achieved by building a high-performance compute cluster to train deep data networks at petabyte scale.

“Mount Sinai is at the forefront of digital health in medicine, with an exceptionally talented team driving innovation forward. I am tremendously excited to join them in expanding initiatives and efforts to advance artificial intelligence in human health; the honor of leading this task is utterly humbling,” said Dr. Fuchs. “Together, we will weave a fabric of AI services that help nurses, physicians, and hospital leadership to make personalized decisions for every patient. The key goals are to help especially vulnerable populations, improve treatment for all, and use AI to democratize health care throughout New York and across the globe.”

His vision for Mount Sinai is to further revolutionize medical practice by pushing the boundaries of AI with the ultimate goal of transforming the quality of life and human health for people all over the globe. That vision includes transforming pathology—the study of causes and effects of a disease or injury—from a qualitative to a quantitative science, and empowering more doctors and medical students to use their talent for good by joining the novel field.

Dr. Fuchs will focus on developing a new system and code for machine learning; large-scale research models and computation; more effectively using data to apply to real-world clinical settings; and continuing to expand the use of computational pathology in treatments through collaboration.

He will co-lead the Hasso Plattner Institute for Digital Health at Mount Sinai, established in 2019 by the Mount Sinai Health System and the Hasso Plattner Institute with generous philanthropic support from the Hasso Plattner Foundation.

“Dr. Fuchs has made key contributions in AI for cancer diagnosis which will be significant as we work to save lives, prevent disease, and improve the health of patients using artificial intelligence in real-time analysis of comprehensive health data from electronic health records, genetic information, and mobile sensor technologies,” said Erwin P. Bottinger, MD, Co-Director of the Hasso Plattner Institute for Digital Health at Mount Sinai and Professor of Digital Health-Personalized Medicine, Hasso Plattner Institute, University of Potsdam, Germany. “As Dr. Fuchs and I collaborate to advance artificial intelligence and machine learning in health care, the institute will continue to be a force in creating progressive digital health services.”

Before joining Mount Sinai, Dr. Fuchs was Director of the Warren Alpert Center for Digital and Computational Pathology at Memorial Sloan Kettering Cancer Center (MSK) and Associate Professor at Weill Cornell Graduate School for Medical Sciences. At MSK he led a laboratory focused on computational pathology and medical machine learning. Dr. Fuchs co-founded Paige.AI in 2017 and led its initial growth to the leading AI company in pathology. He is a former research technologist at NASA’s Jet Propulsion Laboratory and visiting scientist at the California Institute of Technology. Dr. Fuchs holds a Doctor of Sciences from ETH Zurich in Machine Learning and a MS in Technical Mathematics from Graz Technical University in Austria.

“We are very pleased to welcome Thomas to our faculty,” said Eric Nestler, MD, PhD, Nash Family Professor of Neuroscience, Director of The Friedman Brain Institute, and Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai. “His vast knowledge in data science, machine learning, and artificial intelligence will significantly move Mount Sinai forward as a world leader in health care.”

About the Mount Sinai Health System

The Mount Sinai Health System is New York City’s largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care—from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report’s “Honor Roll” of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

Share article on social media or email:

The Book “Plagues, Pandemics and Viruses,” Due Nov. 1, Charts Likely Course COVID Might Take Based on Thousands of Years of Pandemic History


News Image

When Heather Quinlan was hired by Visible Ink Press in 2018 to write a book on pandemics and how they changed the course of human history—including the beginning of the Renaissance and the start of the middle class–she could not have predicted the imminent rise of COVID.

Fast forward to the beginning of 2020, and just as Quinlan was almost finished with her manuscript, her ongoing research introduced her to the novel coronavirus in its infancy.

“It went from murmurs that a SARS-like virus had emerged, to hospitals being built in China within days, to all of a sudden Tom Hanks had it, and then the NBA and NHL talked about canceling their seasons. It was quick and it was terrifying.”

Needless to say, in light of these shattering developments, Quinlan’s deadline was extended.

Quinlan says the prospect of writing about COVID was doubly daunting because, “The information was changing daily, and it was difficult to maintain a journalistic distance while being frightened about what might happen around the world and at home.”

In the midst of the COVID crisis, Quinlan interviewed Dr. Anthony Fauci, the physician most often on the front lines of pandemic research. Fauci told Quinlan, “Here we are in 2020 in the middle of what’s going to turn out to be an historic pandemic.” When asked if rushing a vaccine may result in an even more dangerous version of COVID, Fauci answered with an emphatic “Yes.” Because the FDA is now insisting on stricter guidelines for COVID vaccine developers, Fauci’s take was particularly prescient.

The COVID threat affected Quinlan’s personal life as well. She and her husband became one of the first U.S. couples to be married via Zoom instead of in front of their family and friends.

In addition to COVID, “Plagues, Pandemics, and Viruses: From The Plague of Athens to COVID-19” tracks illnesses that have bedeviled humankind from ancient times to the present day.

Topics include:

WHERE WE ARE PROBABLY HEADED:

  • If history is the judge, based on the three stages of the 1918 Flu, the second wave—which occurred in the fall of that year—was the worst and took the greatest toll


WHEN PLAGUE GAVE PARIS LEMONS:

  • The surprising story of how lemons kept the Great Plague of London out of Paris


UNINTENDED POSITIVE CONSEQUENCES:

  • How the Black Death led to the Renaissance and the rise of the middle class


THE SURPRISING:

  • Why the 1918 Spanish flu had nothing to do with Spain, and how President Woodrow Wilson masked the true scope of its death toll so Americans could fight in WWI; nevertheless, Wilson, as well as his Assistant Secretary of the Navy, Franklin D. Roosevelt, would subsequently catch the flu

ABOUT “Plagues, Pandemics and Viruses”:

“Plagues, Pandemics and Viruses: From the Plague of Athens to COVID-19,” published by Visible Ink Press, is due out November 1. Visible Ink Press is also the publisher of the renowned “Video Hound” and “Music Hound” guides. It is available for pre-order via Amazon or Barnes & Noble.

ABOUT Author Heather Quinlan:

Heather Quinlan got her start in publishing at Discovery Channel Books, then as an Acquisitions Editor for Sterling Publishing. Quinlan is also a filmmaker, whose documentary on the New York accent, “If These Knishes Could Talk,” screened at the Library of Congress and at film festivals around the world.

Share article on social media or email:

CT Defense Launches U.S. Operations, Offering Turn-Key, Mobile Hospital & Military Solutions to Rapidly Deploy During Natural & Manmade Disasters


“Compared to the traditional models of mobile or tent hospitals which are notoriously expensive and difficult to set-up, CT Defense’s flexible mobile infrastructure solutions are designed to directly address the need for speed, efficiency, and lifesaving technology for government organizations.”

CT Defense, a global mobile infrastructure manufacturer, today announced the launch of its U.S. operations following a successful deployment with Florida’s Division of Emergency Management at Winter Haven Hospital to combat the ongoing COVID-19 pandemic. As a provider of mobile hospital systems and military support units, the announcement solidifies CT Defense’s global expansion strategy.

“While the world deals with COVID-19, climate change, and a range of other challenges, it’s critical that our first responders and military are able to deploy rapidly in order to save lives,” said Michael Sayre, U.S. President for CT Defense. “Compared to the traditional models of mobile or tent hospitals which are notoriously expensive and difficult to set-up, CT Defense’s flexible mobile infrastructure solutions are designed to directly address the need for speed, efficiency, and lifesaving technology for government organizations.”

The CT Defense product lineup includes specialty vehicles offering sophisticated, next-generation solutions for military, medical and disaster preparedness applications with two models currently in production. Each mobile unit can be deployed in under three hours with as few as two people.

The two models, Mobile Command Units (MCUs) and Mobile Medical Units (MMUs), are designed to be autonomous for up to 20 days in rough and rugged environments, and can operate as easily in a disaster zone as they can in a parking lot. Each model is 100 KM/HR wind-tested, offers lock-down mode, and has 24/7/365 security monitoring.

The MMU is a comprehensive mobile hospital and offers the highest medical standards, military grade chassis, multiple configurations, advanced telemedicine, negative/positive pressure, 1-12 beds (depending on layout) and communication to fleet command.

For military purposes, the MCU is a mobile forward operating base and includes two units designed to work in tandem. Each unit independently supports 20 people for 20 days, is designed to strict military specifications, has undergone comprehensive testing for more than 20 years, and includes optional long haul upgrades and weather modifications.

CT Defense operates globally from five offices in South America (Rio de Janeiro, Brazil and Mexico City, Mexico) and North America (Los Angeles and Miami and Seattle).

About CT Defense

CT Defense specialty vehicles offer sophisticated, next-generation solutions for the military, medical and disaster preparedness industries. Founded in 1978 under parent company, Traylfer, it employs 350 people globally. Headquartered in Hallandale Beach, FL, the company has built over 5,000 vehicles in its over 40 years of business, and over two decades serving the defense industry. https://ctdefense.co/

Share article on social media or email: